Dianthus Therapeutics, Inc. Share Price
NASDAQ: DNTH | Mid CapDianthus Therapeutics, Inc. Stock Performance
Open $110.07 | Prev. Close $109.73 | Circuit Range N/A |
Day Range $106.89 - $110.47 | Year Range $18.20 - $112.95 | Volume 8,110 |
Average Traded $108.31 |
Dianthus Therapeutics, Inc. Share Price Today
As of 9 August 2026, Dianthus Therapeutics, Inc.'s share price is $107.66. The stock opened at $110.07, compared to its previous close of $109.73. During today's trading session, Dianthus Therapeutics, Inc.'s share price traded between $106.89 and $110.47, with an average price of $108.68. Over the past 52 weeks, the stock has recorded a high of $112.95 and a low of $18.20. In terms of performance, Dianthus Therapeutics, Inc.'s share price has risen by 95.25% over the last six months and is up 357.25% on a year-on-year basis.
Dianthus Therapeutics, Inc. Share Price Chart
Dianthus Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $4.16B | PE Ratio (TTM) -25.63 | Dividend Yield N/A |
EPS (TTM) $-4.20 | Revenue (TTM) $2.04M | Return On Equity (TTM) -32.90% |
Profit Margin -7973.33% | Debt to Equity 0.06 | Quarterly Earnings Growth YoY -46.04% |
Dianthus Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Dianthus Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. The company's lead novel and proprietary monoclonal antibody product candidate includes DNTH103, a human monoclonal immunoglobulin G4 with picomolar that binds the active form of C1s, which is in clinical-stage trials for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Dianthus Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $104.56 | $107.92 | +0.94% |
Jul 2026 | $96.93 | $106.92 | +9.69% |
Jun 2026 | $91.78 | $97.47 | +4.86% |
May 2026 | $89.30 | $92.96 | +5.83% |
Apr 2026 | $86.57 | $87.84 | +4.73% |
Mar 2026 | $53.84 | $83.87 | +52.10% |
Feb 2026 | $52.94 | $55.14 | +3.15% |
Jan 2026 | $41.00 | $53.45 | +29.71% |
Dec 2025 | $43.50 | $41.21 | -6.26% |
Nov 2025 | $34.91 | $43.96 | +25.74% |
Oct 2025 | $39.10 | $34.96 | -11.20% |
Sep 2025 | $24.05 | $39.37 | +67.21% |
DNTH Share Price FAQs
What is Dianthus Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Dianthus Therapeutics, Inc. stock?
What is DNTH's market capitalisation today?
What is DNTH's net income for the last quarter?
What is the 5 year returns of DNTH?
What is the high & low stock price of DNTH today?
Can I buy DNTH shares in India?